.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Polycystic ovary syndrome (PCOS), recently renamed polyendocrine metabolic ovarian syndrome (PMOS), affects millions of women worldwide. Fortunately, clinical research from the All India Institute of Medical Sciences (AIIMS) highlights the power of yoga for PMOS. Specifically, two breakthrough studies demonstrate that mind-body intervention offers therapeutic benefits far beyond simple weight management. Therefore, clinicians should consider incorporating structured yoga programs into standard treatment protocols.
During the 12-week supervised program, participants engaged in regular yoga, pranayama, and meditation sessions. Consequently, the researchers observed a marked improvement in metabolic and hormonal profiles. Specifically, the results showed substantial reductions in body weight, waist circumference, and testosterone levels. Furthermore, the intervention significantly lowered low-density lipoprotein (LDL) cholesterol and improved overall menstrual regularity. These systemic changes help address the underlying abnormalities of the condition.
According to Professor Rima Dada of AIIMS, PMOS is a complex metabolic disorder. Consequently, it increases the long-term risk of diabetes, fatty liver disease, and cardiovascular complications. However, advanced laboratory analyses revealed that yoga modifies the genetic pathways driving these risks. Specifically, yoga improved the expression of genes related to insulin sensitivity, lipid metabolism, and systemic inflammation. Additionally, these biological changes directly target the oxidative stress that drives metabolic dysfunction.
In addition to metabolic benefits, the studies reported an encouraging trend in fertility. Specifically, out of 16 participants struggling with long-standing infertility, seven conceived during or shortly after the program. While pregnancy was not a predefined clinical outcome, these findings are highly promising. Therefore, larger clinical trials are necessary to confirm these reproductive benefits. In conclusion, yoga offers a safe, low-cost, and non-pharmacological addition to standard care.
Q1: What is PMOS, and how does it relate to PCOS?
Polycystic Ovary Syndrome (PCOS) was recently renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) in 2026 to reflect its broader systemic impact on multiple endocrine and metabolic systems, rather than just the ovaries.
Q2: How long was the yoga intervention in the AIIMS study, and what did it include?
The supervised AIIMS program lasted for 12 weeks. It combined regular sessions of physical yoga postures, pranayama (controlled breathing), and meditation.
Q3: Did the AIIMS study observe any positive impact on fertility?
Yes, the researchers reported an encouraging fertility trend. Out of 16 participants with long-standing infertility, seven conceived during the 12-week program or within three months of completing it.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A recent study led by AIIMS Delhi reveals that a 12-week structured yoga program can significantly improve hormonal levels, menstrual regularity, and insulin sensitivity in women with Polyendocrine Metabolic Ovarian Syndrome (PMOS), proving its efficacy as a therapeutic adjunct beyond simple weight loss.
2 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
